KRYS - Krystal Biotech, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$336.40
DETAILS
HIGH:
$371.00
LOW:
$300.00
MEDIAN:
$327.00
CONSENSUS:
$336.40
DOWNSIDE:
10.31%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Dalio | 46,367 | $12.0M | 0.1% | +36,352 | INCREASED |
| Cooperman | 9,400 | $2.4M | 0.0% | +7,292 | INCREASED |
| Greenblatt | 1,323 | $341,757 | 0.0% | +20 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-25 | Thomas John Charles | officer: EVP, General Counsel | M-Exempt | 1,000 | $179.25 | $179K |
| 2026-06-25 | Thomas John Charles | officer: EVP, General Counsel | SELL | 1,000 | $347.27 | $347K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 320 | $300.75 | $96K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 480 | $305.87 | $147K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 1,348 | $307.09 | $414K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 12,729 | $307.81 | $3.9M |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 240 | $311.65 | $75K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 589 | $306.33 | $180K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 964 | $311.36 | $300K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 593 | $302.25 | $179K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 247 | $303.17 | $75K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 2,801 | $309.95 | $868K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 320 | $300.75 | $96K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 176 | $303.17 | $53K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 400 | $304.89 | $122K |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 2,039 | $310.94 | $634K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 40 | $312.23 | $12K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 11,461 | $307.68 | $3.5M |
| 2026-06-04 | Krishnan Suma | director, 10 percent owner, officer: President, R&D | SELL | 3,803 | $308.89 | $1.2M |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 4,830 | $308.47 | $1.5M |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 2,784 | $309.49 | $862K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 640 | $302.24 | $193K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 2,652 | $310.43 | $823K |
| 2026-06-04 | Krishnan Krish S | director, 10 percent owner, officer: President and CEO | SELL | 544 | $304.81 | $166K |
| 2026-05-26 | Thomas John Charles | officer: EVP, General Counsel | SELL | 642 | $302.03 | $194K |